ZA200605721B - The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same - Google Patents
The glucagon-like peptide-1 receptor agonists, the preparation and the use of the sameInfo
- Publication number
- ZA200605721B ZA200605721B ZA200605721A ZA200605721A ZA200605721B ZA 200605721 B ZA200605721 B ZA 200605721B ZA 200605721 A ZA200605721 A ZA 200605721A ZA 200605721 A ZA200605721 A ZA 200605721A ZA 200605721 B ZA200605721 B ZA 200605721B
- Authority
- ZA
- South Africa
- Prior art keywords
- glucagon
- peptide
- preparation
- same
- receptor agonists
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/42—Oxazoles
- A61K31/421—1,3-Oxazoles, e.g. pemoline, trimethadione
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/12—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings linked by a chain containing hetero atoms as chain links
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/425—Thiazoles
- A61K31/426—1,3-Thiazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Diabetes (AREA)
- Epidemiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Child & Adolescent Psychology (AREA)
- Plural Heterocyclic Compounds (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Peptides Or Proteins (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Indole Compounds (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CNB2003101093310A CN100453533C (zh) | 2003-12-12 | 2003-12-12 | 一类胰高血糖样肽－1受体激动剂及其制备方法和用途 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ZA200605721B true ZA200605721B (en) | 2007-04-25 |
Family
ID=34661371
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| ZA200605721A ZA200605721B (en) | 2003-12-12 | 2006-07-11 | The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same |
Country Status (13)
| Country | Link |
|---|---|
| US (1) | US7838682B2 (ru) |
| EP (1) | EP1695968A4 (ru) |
| JP (1) | JP4527665B2 (ru) |
| KR (1) | KR100764863B1 (ru) |
| CN (1) | CN100453533C (ru) |
| AU (1) | AU2003296205B2 (ru) |
| BR (1) | BR0318631A (ru) |
| CA (1) | CA2549355A1 (ru) |
| IL (1) | IL176223A0 (ru) |
| RU (1) | RU2342368C2 (ru) |
| UA (1) | UA87122C2 (ru) |
| WO (1) | WO2005056537A1 (ru) |
| ZA (1) | ZA200605721B (ru) |
Families Citing this family (12)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1884278A (zh) * | 2005-06-24 | 2006-12-27 | 中国科学院上海药物研究所 | 一类胰高血糖样肽－1受体调节剂、制备方法和用途 |
| CN1896069B (zh) * | 2005-07-15 | 2011-10-05 | 中国科学院上海药物研究所 | 一类取代噻唑-4酮化合物、制备方法和用途 |
| CN101195584A (zh) * | 2006-12-05 | 2008-06-11 | 中国科学院上海药物研究所 | 一类具有取代环丙烷结构的化合物、制备方法及其医学用途 |
| CN101195613B (zh) * | 2006-12-05 | 2012-08-08 | 中国科学院上海药物研究所 | 一类具有取代四元环结构的化合物及其医学用途 |
| CN101195586A (zh) * | 2006-12-05 | 2008-06-11 | 中国科学院上海药物研究所 | 一类具有取代环戊烷结构的化合物、制备方法及其医学用途 |
| CN101195585A (zh) * | 2006-12-05 | 2008-06-11 | 中国科学院上海药物研究所 | 一类具有取代环己烷结构的化合物、及其制备方法和医学用途 |
| CN101195612B (zh) * | 2006-12-05 | 2012-08-08 | 中国科学院上海药物研究所 | 一类具有取代环丁烷结构的化合物、及其制备方法和医学用途 |
| CN101274927B (zh) * | 2007-03-29 | 2011-04-27 | 中国科学院上海药物研究所 | 一类四元环状化合物的光化学反应制备方法及其用途 |
| WO2011048614A2 (en) | 2009-10-22 | 2011-04-28 | Cadila Healthcare Limited | Short chain peptidomimetics based orally active glp-1 agonist and glucagon receptor antagonist |
| WO2012101292A1 (es) | 2011-01-25 | 2012-08-02 | Viviabiotech, S.L. | Derivados de 1,2,4-oxadiazol como fármacos moduladores del receptor para el péptido glp-1 |
| US9409006B2 (en) | 2011-04-10 | 2016-08-09 | David Hirshberg | Fat removal device and obesity treatment |
| US20220193041A1 (en) * | 2019-04-02 | 2022-06-23 | Yonsei University, University - Industry Foundation (UIF) | Novel compound and method for preventing or treating of respiratory diseases comprising the same as an active ingredient |
Family Cites Families (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS5811950B2 (ja) * | 1976-12-25 | 1983-03-05 | 味の素株式会社 | ２，４−置換−５−オキサゾロンの製法 |
| US4912221A (en) * | 1988-10-27 | 1990-03-27 | Occidental Chemical Corporation | Chiral 1,2,3,4-tetrahydroisoquinoline-3-carboxylic acid and precursors and preparation thereof |
| JPH0350532A (ja) * | 1989-07-19 | 1991-03-05 | Ajinomoto Co Inc | 有機非線形光学材料 |
| JPH09244229A (ja) * | 1996-03-07 | 1997-09-19 | Toshiba Corp | 感光性組成物及びそれを用いたパターン形成方法 |
| JP3050532B2 (ja) * | 1997-04-02 | 2000-06-12 | 山進工業株式会社 | ロール |
| JP3092583B2 (ja) * | 1998-03-23 | 2000-09-25 | 日本電気株式会社 | 有機エレクトロルミネッセンス素子材料およびそれを使用した有機エレクトロルミネッセンス素子 |
| TW200304375A (en) * | 2001-12-06 | 2003-10-01 | Maxia Pharmaceuticals Inc | 2-Substituted thiazolidinone and oxazolidinone derivatives for the inhibition of phosphatases and the treatment of cancer |
-
2003
- 2003-12-12 CN CNB2003101093310A patent/CN100453533C/zh not_active Expired - Fee Related
- 2003-12-25 EP EP03785463A patent/EP1695968A4/en not_active Withdrawn
- 2003-12-25 RU RU2006124796/04A patent/RU2342368C2/ru not_active IP Right Cessation
- 2003-12-25 CA CA002549355A patent/CA2549355A1/en not_active Abandoned
- 2003-12-25 KR KR1020067013965A patent/KR100764863B1/ko not_active IP Right Cessation
- 2003-12-25 JP JP2005511631A patent/JP4527665B2/ja not_active Expired - Fee Related
- 2003-12-25 BR BRPI0318631-8A patent/BR0318631A/pt not_active IP Right Cessation
- 2003-12-25 AU AU2003296205A patent/AU2003296205B2/en not_active Ceased
- 2003-12-25 US US10/582,580 patent/US7838682B2/en not_active Expired - Fee Related
- 2003-12-25 WO PCT/CN2003/001115 patent/WO2005056537A1/zh active Application Filing
- 2003-12-25 UA UAA200607009A patent/UA87122C2/ru unknown
-
2006
- 2006-06-08 IL IL176223A patent/IL176223A0/en unknown
- 2006-07-11 ZA ZA200605721A patent/ZA200605721B/xx unknown
Also Published As
| Publication number | Publication date |
|---|---|
| JP2007523828A (ja) | 2007-08-23 |
| RU2006124796A (ru) | 2008-01-27 |
| IL176223A0 (en) | 2006-10-05 |
| US20070043093A1 (en) | 2007-02-22 |
| AU2003296205B2 (en) | 2008-09-25 |
| UA87122C2 (ru) | 2009-06-25 |
| CA2549355A1 (en) | 2005-06-23 |
| CN1626521A (zh) | 2005-06-15 |
| KR20060097065A (ko) | 2006-09-13 |
| EP1695968A1 (en) | 2006-08-30 |
| JP4527665B2 (ja) | 2010-08-18 |
| AU2003296205A1 (en) | 2005-06-29 |
| EP1695968A4 (en) | 2007-08-22 |
| US7838682B2 (en) | 2010-11-23 |
| WO2005056537A1 (fr) | 2005-06-23 |
| CN100453533C (zh) | 2009-01-21 |
| KR100764863B1 (ko) | 2007-10-09 |
| BR0318631A (pt) | 2006-10-31 |
| RU2342368C2 (ru) | 2008-12-27 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ZA200605721B (en) | The glucagon-like peptide-1 receptor agonists, the preparation and the use of the same | |
| AU2003273300A8 (en) | Modified glp-1 receptor agonists and their pharmacological methods of use | |
| IL183940A0 (en) | Glp-1 agonists, compositions, methods and uses | |
| ZA200409333B (en) | 4-substituted imidazole-2-thiones and imidazol-2-ones as agonists of the alpha-2B and alpha-2C adrenergic receptors. | |
| AU2002366384A8 (en) | Insulin and igf-1 receptor agonists and antagonists | |
| HK1099556A1 (en) | Fused heterocyclic derivative, medicinal composition containing the same, and medicinal use thereof | |
| HUP0201033A2 (hu) | Glukagon antagonisták és inverz agonisták, eljárás az előállításukra és alkalmazásuk | |
| IL178432A0 (en) | Human glp-1 mimetibodies, compositions, methods and uses | |
| HK1079518A1 (en) | Quinazolinone derivatives and their use as cb agonists | |
| EP1541585A4 (en) | CXCR4 ANTAGONIST AND USE THEREOF | |
| AU2003265853A8 (en) | Hedgehog antagonists, methods and uses related thereto | |
| AU2003236205A1 (en) | Glucagon antagonists/inverse agonists | |
| AU2003238597A8 (en) | Benzimidazole compounds and their use as estrogen agonists/antagonists | |
| IL197774A0 (en) | Corticotropin releasing factor 2 receptor agonists | |
| PL378244A1 (pl) | Pirolilotiazole i ich zastosowanie jako odwrotnych agonistów receptora CB 1 | |
| ZA200710699B (en) | Piperazine-piperidine antagonists and agonists of the 5-HT1A receptor | |
| HK1074446A1 (en) | 3-phenyl substituted pyridoindolone, preparation and therapeutic use thereof | |
| IL173521A0 (en) | Substituted 2 - carbonylamino - 6 piperidinaminopyidines and substituted 1 - carbonylamino - 3 - piperidinaminobenzenes as 5 - th1f agonists | |
| PL370221A1 (en) | 2-oxazolamines and their use as 5-ht2b receptor antagonists | |
| AU2003210062A1 (en) | Agonists and antagonists of gonadotropin-releasing hormone-2, and use thereof | |
| GB0305089D0 (en) | Composition, use and process | |
| AU2003300122A1 (en) | Agonists and antagonists of the human odorant receptor or17-4 and uses thereof | |
| ZA200608999B (en) | Human GLP-1 mimetibodies, compositions, methods and uses | |
| GB0229445D0 (en) | Process,composition and use | |
| GB2420345B (en) | 3-alpha-glycosyl alpha, alpha-trehaloses their preparation and use |